Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/02/11 | 3/A | F-1MEF |
|
2 | |
| 10/31/11 | 4/A | F-4MEF |
|
2 | |
| 10/31/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/17/11 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
2 | |
| 10/13/11 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/07/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
41 | |
| 09/23/11 | 8-K | Current report filing |
|
5 | |
| 09/09/11 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
40 | |
| 09/08/11 | 8-K | Current report filing |
|
5 | |
| 08/29/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 |
